CymitQuimica logo
CDK

CDK

Gli inibitori delle chinasi ciclina-dipendenti (CDK) sono composti che bloccano l'attività delle CDK, un gruppo di chinasi proteiche che regolano il ciclo cellulare, la trascrizione e altri processi cellulari. Le CDK vengono attivate legandosi alle cicline e la loro attività è cruciale per la progressione delle cellule attraverso le diverse fasi del ciclo cellulare. Inibire le CDK può bloccare la divisione cellulare, portando all'arresto del ciclo cellulare e all'apoptosi, in particolare nelle cellule tumorali in cui le CDK sono spesso disregolate. Gli inibitori delle CDK sono ampiamente utilizzati nella ricerca sul cancro e hanno un potenziale terapeutico nel trattamento di vari tipi di cancro. Presso CymitQuimica, offriamo una selezione completa di inibitori delle CDK di alta qualità per supportare la tua ricerca sul controllo del ciclo cellulare, sul cancro e sullo sviluppo terapeutico.

Trovati 522 prodotti di "CDK"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • Mevociclib

    CAS:
    Mevociclib (SY-1365) is a highly selective covalent inhibitor of CDK7. SY-1365 possesses therapeutic potential in both hematological and solid tumors.
    Formula:C31H35ClN8O2
    Purezza:98.02% - 98.02%
    Colore e forma:Solid
    Peso molecolare:587.11
  • Xylocydine

    CAS:
    Xylocydine is a novel Cdk inhibitor that induces apoptosis in HCC, suppresses tumor growth, and is non-toxic to other tissues.
    Formula:C12H14BrN5O5
    Colore e forma:Solid
    Peso molecolare:388.17
  • Cdc7-IN-7

    CAS:
    <p>Cdc7-IN-7 is a potent inhibitor of Cdc7 kinase.</p>
    Formula:C21H22N4O5
    Purezza:98.78%
    Colore e forma:Solid
    Peso molecolare:410.42
  • Cdc7-IN-12

    CAS:
    Cdc7-IN-12, a sub-1 nM CDC7 inhibitor, may aid cancer research; hinders COLO205 cell growth (IC50: 100-1000 nM).
    Formula:C16H14N2O2S
    Colore e forma:Solid
    Peso molecolare:298.36
  • CDK4/6-IN-15

    CAS:
    CDK4/6-IN-15: Oral, selective CDK4/6 inhibitor, halts cancer cell growth, G1 arrest, suppresses Rb phosphorylation.
    Formula:C21H27FN8S
    Colore e forma:Solid
    Peso molecolare:442.56
  • SZ-015268

    CAS:
    SZ-015268: CDK7 inhibitor, IC50=23.56 nM; hinders HCC70, OVCAR-3, HCT116, HCC1806 cell growth; strong anti-tumor effect.
    Formula:C25H38N8O3
    Colore e forma:Solid
    Peso molecolare:498.62
  • NU6300

    CAS:
    NU6300 is a covalent CDK2 inhibitor exhibiting irreversible and ATP-competitive properties and also functions as a GSDMD (Gasdermin D) inhibitor.
    Formula:C20H23N5O3S
    Purezza:96.08%
    Colore e forma:Solid
    Peso molecolare:413.49
  • CDK8-IN-3

    CAS:
    CDK8-IN-3 is an inhibitor of CDK8.
    Formula:C22H23N5O2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:389.45
  • CDK4/6-IN-17

    CAS:
    CDK4/6-IN-17 (compound 12) is an orally bioavailable inhibitor of CDK4/6, demonstrating potent activity with IC50 values between 10-100 nM in BE(2) cells.
    Formula:C27H28F4N8
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:540.56
  • CDK9-IN-29

    CAS:
    <p>CDK9-IN-29 (compound Z11) is a potent inhibitor of CDK9, exhibiting high kinase selectivity and an IC50 value of 3.20 nM.</p>
    Formula:C29H33F2N5O4
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:553.6
  • Palbociclib orotate

    CAS:
    <p>Palbociclib (PD 0332991) orotate, an orally active selective inhibitor of CDK4 and CDK6, exhibits IC50 values of 11 and 16 nM, respectively.</p>
    Formula:C29H33N9O6
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:603.63
  • (2S,3R)-Voruciclib

    CAS:
    (2S,3R)-Voruciclib is the (2S,3R)-enantiomer of Voruciclib. It is an orally active CDK inhibitor.
    Formula:C22H19ClF3NO5
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:469.84
  • QR-6401

    CAS:
    <p>QR-6401, a selective macrocyclic CDK2 inhibitor, is orally active with IC50 values of 0.37 nM for CDK2/E1, 10 nM for CDK9/T1, 22 nM for CDK1/A2, 34 nM for CDK6/</p>
    Formula:C19H23N5O3
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:369.42
  • CDK/HDAC-IN-3

    CAS:
    <p>CDK/HDAC-IN-3 is an orally active dual inhibitor of HDACs and CDKs, offering potent and selective inhibition of CDK9, CDK12, CDK13, HDAC1, HDAC2, and HDAC3,</p>
    Formula:C24H18Cl2N6O3
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:509.34
  • PF-6808472

    CAS:
    PF-6808472 is a cell-permeable covalent kinase probe, reacts with conserved lysine residues within the ATP-binding site of kinases.
    Formula:C25H27FN8O3S
    Purezza:99.02%
    Colore e forma:Solid
    Peso molecolare:538.6
  • HQ005

    CAS:
    HQ005, a potent CCNK degrader, exhibits an impressive DC50 value of 0.041 µM and functions as a molecular-glue degrader.
    Formula:C15H15N5O2S2
    Colore e forma:Solid
    Peso molecolare:361.44
  • Senexin A hydrochloride

    CAS:
    Senexin A hydrochloride functions as a selective inhibitor of CDK8/19, with an IC 50 of 280 nM for CDK8, and specifically inhibits p21-induced transcription without affecting other biological effects of p21. Additionally, it suppresses CMV-GFP induction and the stimulatory activity of the consensus NF-κB-dependent promoters [1] [2].
    Formula:C17H15ClN4
    Colore e forma:Solid
    Peso molecolare:310.78
  • Nε-(1-Carboxyethyl)-L-lysine

    CAS:
    Nε-(1-Carboxyethyl)-L-lysine (CEL) is an advanced glycation end-product (AGE). Exposure to CEL reduces glutamate uptake and S100B secretion in the hippocampus.
    Formula:C9H18N2O4
    Colore e forma:Solid
    Peso molecolare:218.25
  • LDC3140

    CAS:
    LDC3140 is a potent inhibitor of Cyclin-dependent kinase 7 (CDK7).
    Formula:C23H33N7O
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:423.55
  • CDK9-IN-9

    CAS:
    <p>CDK9-IN-9 is a potent and selective CDK9 inhibitor (IC50: 1.8 nM) with anti-cancer activity. It inhibits CDK2 (IC50: 155 nM).</p>
    Formula:C22H23F2N5O2S
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:459.51
  • CDK9-IN-19

    CAS:
    CDK9-IN-19: Potent CDK9 inhibitor, anti-cancer, moderate pharmacokinetics, low hERG impact, effective in AML research.
    Formula:C26H22F2N4O5
    Colore e forma:Solid
    Peso molecolare:508.47
  • 5-Iodo-indirubin-3'-monoxime

    CAS:
    5-Iodo-indirubin-3'-monoxime is a potent GSK-3β, CDK5/P25 and CDK1/cyclin B inhibitor, competing with ATP for binding to the catalytic site of the kinase (IC50s
    Formula:C16H10IN3O2
    Colore e forma:Solid
    Peso molecolare:403.17
  • CDK7-IN-14

    CAS:
    <p>CDK7-IN-14, a potent CDK7 inhibitor from pyrimidines, may treat transcriptionally dysregulated cancers (CN114249712A).</p>
    Formula:C22H24F3N6OP
    Colore e forma:Solid
    Peso molecolare:476.43
  • DCB-3503

    CAS:
    DCB-3503, a tylophorine analog, may fight cancer and aid immunosuppression by hindering protein synthesis and modulating HSC70 ATPase function.
    Formula:C24H27NO5
    Colore e forma:Solid
    Peso molecolare:409.47
  • Voruciclib hydrochloride

    CAS:
    Voruciclib hydrochloride is an orally active and selective inhibitor of CDK (Ki: 0.626 nM-9.1 nM).
    Formula:C22H20Cl2F3NO5
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:506.3
  • Inixaciclib

    CAS:
    Inixaciclib is a potent CDK inhibitor, can be used to research anticancer.
    Formula:C26H30F2N6O
    Colore e forma:Solid
    Peso molecolare:480.55
  • KM05382

    CAS:
    KM05382 inhibits CDK9 and the transcription of GAPDH.
    Formula:C20H19ClN2O3S2
    Colore e forma:Solid
    Peso molecolare:434.96
  • Riviciclib

    CAS:
    Riviciclib, a CDK inhibitor (CDK9/T1, CDK4/D1, CDK1/B), has IC50s: 20, 63, 79 nM respectively, and fights cisplatin-resistant tumors.
    Formula:C21H20ClNO5
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:401.84
  • Cdk4 Inhibitor

    CAS:
    PD 0332991, an unsymmetrical indolocarbazole compound, is cell-permeable and exhibits antiproliferative effects by functioning as a potent, selective, reversible, and ATP-competitive inhibitor of Cdk4/D1 (IC 50 = 76 nM). Although it can inhibit other Cdks, such as Cdk2/E and Cdk1/B, effectiveness requires higher concentrations (IC 50 = 520 nM and 2.1 µM, respectively) and demonstrates minimal activity against CaMKII, PKA, or GSK-3β (IC 50 ≥ 12.4 µM). PD 0332991 efficiently inhibits tumor cell growth in HCT-116 and NCI-H460 cell lines with an IC 50 < 3.0 µM, primarily through blocking Rb phosphorylation and inducing G1 cell cycle arrest.
    Formula:C20H10BrN3O2
    Colore e forma:Solid
    Peso molecolare:404.2
  • CCT-251921

    CAS:
    CCT-251921 is a potent, selective, and orally bioavailable CDK8 inhibitor (IC50: 2.3 nM).
    Formula:C21H23ClN6O
    Purezza:99.07%
    Colore e forma:Solid
    Peso molecolare:410.9
  • ML 315 hydrochloride

    CAS:
    <p>ML 315, a selective dual inhibitor targeting CDK (Cyclin-Dependent Kinase) and DYRK (Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase) with IC50 values of 68 nM and 282 nM, respectively, is utilized in research pertaining to cancer and neurological diseases [1].</p>
    Formula:C18H14Cl3N3O2
    Colore e forma:Solid
    Peso molecolare:410.682
  • Senexin C

    CAS:
    Senexin C is a CDK8/19 inhibitor with anticancer activity.Senexin C inhibits the growth of MV4-11 leukemia cells.
    Formula:C28H27N5O
    Purezza:98.06%
    Colore e forma:Solid
    Peso molecolare:449.55
  • CDK7-IN-22

    CAS:
    CDK7-IN-22 (compound 101) is a selective CDK7 inhibitor that exhibits antitumor activity, demonstrating specificity for CDK7 [1].
    Formula:C22H25F3N6
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:430.47
  • CDK9-IN-23

    CAS:
    CDK9-IN-23 (Example 4) is a potent inhibitor of CDK9, exhibiting an IC50 value of less than 20 nM [1].
    Formula:C22H25ClN4O3
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:428.91
  • SHP2/CDK4-IN-1

    CAS:
    SHP2/CDK4-IN-1: dual inhibitor, oral, potent (IC50: SHP2 4.3 nM, CDK4 18.2 nM), hinders TNBC growth, strong antitumor effects in mice.
    Formula:C33H35ClF2N10OS
    Colore e forma:Solid
    Peso molecolare:693.21
  • EHT 5372

    CAS:
    EHT 5372 inhibits DYRK kinases; IC50: 0.22-221 nM for DYRK1A/B, DYRK2/3, CLK1/2/4, GSK-3α/β.
    Formula:C17H11Cl2N5OS
    Colore e forma:Solid
    Peso molecolare:404.27
  • Leucettinib-92

    CAS:
    Leucettinib-92 (compound 92) is a kinase inhibitor selective for DYRK/CLK families, displaying IC50 values of 147 nM (CLK1), 39 nM (CLK2), 5.2 nM (CLK4), 0.8 μM
    Formula:C21H22N4OS
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:378.49
  • CDK7-IN-25

    CAS:
    CDK7-IN-25 (CY-16-1) is a potent CDK7 inhibitor with an IC50 value of less than 1nM, utilized in cancer research [1].
    Formula:C33H32N6O3
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:560.65
  • CDK4-IN-2

    CAS:
    CDK4-IN-2 (A17) is a potent inhibitor of CDK4, exhibiting K i and IC 50 values of less than 10 nM and is utilized in cancer research [1].
    Formula:C22H26F2N6O4S
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:508.54
  • CF53

    CAS:
    CF53: potent, selective oral BET inhibitor; Ki <1 nM, Kd 2.2 nM, IC50 2 nM for BRD4 BD1; high affinity for BRD2/3/4/BRDT; effective anti-tumor agent.
    Formula:C24H25N7O2
    Purezza:99.72%
    Colore e forma:Solid
    Peso molecolare:443.5
  • XY028-140

    CAS:
    <p>XY028-140 is a selective CDK4/6 inhibitor and degrader, acting via PROTAC with ligands for Cereblon and CDK in cancer cells.</p>
    Formula:C39H40N10O7
    Purezza:98.59%
    Colore e forma:Solid
    Peso molecolare:760.8
  • AZD4573

    CAS:
    AZD4573 is an effective and selective CDK9 inhibitor (IC50: <4 nM). It enables transient target engagement for the treatment of hematologic malignancies.
    Formula:C22H28ClN5O2
    Purezza:99% - 99.51%
    Colore e forma:Solid
    Peso molecolare:429.94
  • Debio-0123

    CAS:
    Debio-0123: potent, specific oral WEE1 inhibitor; IC50 in low nanomolar; boosts DNA damage & Carboplatin's anti-cancer effects.
    Formula:C26H28Cl2N6O
    Purezza:99.93%
    Colore e forma:Solid
    Peso molecolare:511.45
  • (R)-Simurosertib

    CAS:
    <p>(R)-Simurosertib ((R)-TAK-931) is an inhibitor of the ATP-competitive cell division cycle 7 (CDC7) kinase.</p>
    Formula:C17H19N5OS
    Purezza:99.89%
    Colore e forma:Solid
    Peso molecolare:341.43
  • Cdk1/2 Inhibitor III

    CAS:
    <p>Cdk1/2 Inhibitor III is a selective Cdk1/2 inhibitor with an IC50 value of 2.1 μM against CDK1/cyclin B.</p>
    Formula:C15H13F2N7O2S2
    Purezza:99.07%
    Colore e forma:Solid
    Peso molecolare:425.44
  • Cimpuciclib tosylate

    CAS:
    Cimpuciclib tosylate, a selective CDK4 inhibitor (IC50: 0.49 nM), exhibits anti-tumor activity.
    Formula:C37H43FN8O4S
    Colore e forma:Solid
    Peso molecolare:714.85
  • CDK9-IN-11

    CAS:
    CDK9-IN-11 is a potent CDK9 inhibitor that is the ligand for the PROTAC CDK9 Degrader-1 [1].
    Formula:C20H25N3O4
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:371.43
  • CDK7-IN-18

    CAS:
    CDK7-IN-18: potent, pyrimidine-based CDK7 inhibitor with cancer research potential.
    Formula:C22H24F3N7OS
    Purezza:99.28%
    Colore e forma:Solid
    Peso molecolare:491.53
  • CDK1-IN-7

    CAS:
    <p>CDK1-IN-7 (compound M7) is a potent CDK1 inhibitor. It effectively suppresses the proliferation and migration of HCT116 and Lovo cells, making it a valuable tool for colorectal cancer research.</p>
    Formula:C23H19ClN4O3
    Colore e forma:Solid
    Peso molecolare:434.88
  • PPA-037

    CAS:
    <p>PPA-037 is an orally active and highly selective inhibitor of cyclin-dependent kinase 12 (CDK12). It induces the degradation of Cyclin K, thereby enhancing antiproliferative effects on tumor cells. PPA-037 holds potential for use in cancer research.</p>
    Formula:C25H27N7
    Colore e forma:Solid
    Peso molecolare:425.53